Pipeline
| Pipeline | Indication | Discovery | Lead Optimization |
Pre-clinical | Phase1 | Phase2 | Phase3 | NDA | ||||||
| FM101 | Nonalcoholic Steatohepatitis(NASH) | |||||||||||||
| FM801 | 비만치료제 | |||||||||||||
| FM101 | Glaucoma | |||||||||||||
| Diabetic Nephropathy | ||||||||||||||
| Primary biliary cholangitis(PBC) | ||||||||||||||
| FM301 | Refractory Pancreatic Cancer | |||||||||||||
| FM401 | Solid Tumors | |||||||||||||
| FM701 | Non Small Cell Lung Cancer(NSCLC) | |||||||||||||
| FM203 | Viral Infections (COVID19, MERS, Zika) | |||||||||||||
| FM503 | Autoimmune Disease | |||||||||||||
| Pipeline | Indication | Graph |
| FM101 | Nonalcoholic Steatohepatitis(NASH) | Phase2 |
| FM801 | 비만치료제 | Pre-Clinical |
| FM101 | Glaucoma | Phase2 |
| Diabetic Nephropathy | Phase1 |
|
| Primary biliary cholangitis(PBC) | Phase1 |
|
| FM301 | Refractory Pancreatic Cancer | Pre-Clinical |
| FM401 | Solid Tumors | Pre-Clinical |
| FM701 | Non Small Cell Lung Cancer(NSCLC) | Pre-Clinical |
| FM203 | Viral Infections (COVID19, MERS, Zika) |
Pre-Clinical |
| FM503 | Autoimmune Disease | Pre-Clinical |
| Pipeline | Indication | Graph |
| FM101 | Nonalcoholic Steatohepatitis(NASH) | Phase2 |
| FM801 | 비만치료제 | Pre-Clinical |
| FM101 | Glaucoma | Phase2 |
| Diabetic Nephropathy | Phase1 |
|
| Primary biliary cholangitis(PBC) | Phase1 |
|
| FM301 | Refractory Pancreatic Cancer | Pre-Clinical |
| FM401 | Solid Tumors | Pre-Clinical |
| FM701 | Non Small Cell Lung Cancer(NSCLC) | Pre-Clinical |
| FM203 | Viral Infections (COVID19, MERS, Zika) |
Pre-Clinical |
| FM503 | Autoimmune Disease | Pre-Clinical |
